188 related articles for article (PubMed ID: 8362283)
21. Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease.
Vaiphei K; Kumari N; Sinha SK; Dutta U; Nagi B; Joshi K; Singh K
World J Gastroenterol; 2006 Jun; 12(22):3602-8. PubMed ID: 16773719
[TBL] [Abstract][Full Text] [Related]
22. [Alpha-heavy chain disease--Mediterranean lymphoma].
Kaufmann HP; Schmitt W; Seib HJ
Leber Magen Darm; 1994 Feb; 24(1):32-5. PubMed ID: 8145624
[TBL] [Abstract][Full Text] [Related]
23. Ulcerative colitis in Thailand: a clinical study and long term follow-up.
Pongprasobchai S; Manatsathit S; Leelakusolvong S; Sattawatthamrong Y; Boonyapisit S
J Med Assoc Thai; 2001 Sep; 84(9):1281-8. PubMed ID: 11800302
[TBL] [Abstract][Full Text] [Related]
24. Malabsorption associated with nonmalignant immunoproliferative small intestinal disease.
Manousos O; Economidou J; Papademetriou C; Triantaphyllidis J; Constandinidou N; Stathopoulos A
Digestion; 1987; 36(3):182-8. PubMed ID: 3596077
[TBL] [Abstract][Full Text] [Related]
25. Results of laparotomy in immunoproliferative small intestinal disease.
Tabbane F; Mourali N; Cammoun M; Najjar T
Cancer; 1988 Apr; 61(8):1699-706. PubMed ID: 3349430
[TBL] [Abstract][Full Text] [Related]
26. Alpha-heavy chain disease, Mediterranean lymphoma, and immunoproliferative small intestinal disease: a review of clinicopathological features, pathogenesis, and differential diagnosis.
Fine KD; Stone MJ
Am J Gastroenterol; 1999 May; 94(5):1139-52. PubMed ID: 10235185
[TBL] [Abstract][Full Text] [Related]
27. [Primary immunoproliferative small intestinal disease].
Nardulli Fernández G; Sukerman V; Marsicano L; Ramón Poleo JR; Hernández D; Almosny I; Olavarría R
G E N; 1995; 49(3):238-42. PubMed ID: 8598264
[TBL] [Abstract][Full Text] [Related]
28. [Alpha heavy chain disease. A Tunisian case].
Ben Ammar A; Cheikh I; Jouini M; Belkahla N; Fadhel SF; Hager O; Maamouri N; Chaabouni H; Ben Safta Z; Haouet S
Tunis Med; 2006 Sep; 84(9):581-4. PubMed ID: 17263208
[TBL] [Abstract][Full Text] [Related]
29. Immunoproliferative small-intestinal disease: follow-up of an alpha-chain negative, lymphoma-free group.
Gilinsky NH; Novis BH; Mee AS; Wright JP; Price S; Marks IN
J Clin Gastroenterol; 1983 Oct; 5(5):421-8. PubMed ID: 6415158
[TBL] [Abstract][Full Text] [Related]
30. [Immunoproliferative disease of the small intestine. Report of a case].
Márquez JL; Mota R; Herrera JM; Narváez I; Sáenz de Santamaría J
Rev Esp Enferm Dig; 1993 May; 83(5):381-3. PubMed ID: 8318283
[TBL] [Abstract][Full Text] [Related]
31. Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience.
Akbulut H; Soykan I; Yakaryilmaz F; Icii F; Aksoy F; Haznedaroglu S; Yildirim S
Cancer; 1997 Jul; 80(1):8-14. PubMed ID: 9210703
[TBL] [Abstract][Full Text] [Related]
32. Immunoproliferative small intestinal disease in Mexico. Report of four cases and review of the literature.
Arista-Nasr J; González-Romo MA; Mantilla-Morales A; Lazos-Ochoa M; Ortiz-Hidalgo C
J Clin Gastroenterol; 1994 Jan; 18(1):67-71. PubMed ID: 8113590
[TBL] [Abstract][Full Text] [Related]
33. Treating chronic diarrhea: A systematic review on Immunoproliferative Small Intestinal Disease (IPSID).
Evangelista-Leite D; Affonso Madaloso B; Shouta Yamashita B; Enrico Aloise F; Polito Verdasca L; Lopes de Mello M; Murata Hayashi R; Zimberg Chehter E
PLoS One; 2021; 16(7):e0253695. PubMed ID: 34270561
[TBL] [Abstract][Full Text] [Related]
34. Pigmented nails and Strongyloides stercoralis infestation causing clinical worsening in a patient treated for immunoproliferative small intestinal disease: two unusual observations.
Ghoshal UC; Saha J; Ghoshal U; Ray BK; Santra A; Naik S; Mazumder DN
J Diarrhoeal Dis Res; 1999 Mar; 17(1):43-5. PubMed ID: 10892497
[TBL] [Abstract][Full Text] [Related]
35. Immunoproliferative small intestinal disease in a 16-year-old boy presenting as severe malabsorption with excellent response to tetracycline treatment.
Zamir A; Parasher G; Moukarzel AA; Guarini L; Zeien L; Feldman F
J Clin Gastroenterol; 1998 Jul; 27(1):85-9. PubMed ID: 9706780
[TBL] [Abstract][Full Text] [Related]
36. [Intestinal non-Hodgkin lymphoma: "immunoproliferative small intestinal disease"].
Mrabti H; Raiss G; Raissouni S; Tazi el M; Inghaouen H; El Ghissassi I; Errihani H
Presse Med; 2011 Nov; 40(11):995-1000. PubMed ID: 21458210
[TBL] [Abstract][Full Text] [Related]
37. Immunoproliferative small intestinal disease versus colonic monoblastic sarcoma in a 2-year-old boy.
Miron I; Mihăilă D; Aprodu G; Miron L; Plămădeală P; Moisă SM
Rom J Morphol Embryol; 2009; 50(4):733-8. PubMed ID: 19942975
[TBL] [Abstract][Full Text] [Related]
38. The Evolution of Our Understanding of Immunoproliferative Small Intestinal Disease (IPSID) over Time.
AlYamany R; Kharfan-Dabaja MA; Hamadani M; Alshaibani A; Aljurf M
Curr Oncol; 2022 May; 29(5):3759-3769. PubMed ID: 35621691
[TBL] [Abstract][Full Text] [Related]
39. Falsely elevated anti-tissue transglutaminase antibodies in patients with immunoproliferative small intestinal diseases: A case series.
Mohta S; Agarwal A; Banyal V; Singh A; Bagchi S; Das P; Ahuja V; Makharia G
Indian J Gastroenterol; 2023 Oct; 42(5):713-717. PubMed ID: 37166700
[TBL] [Abstract][Full Text] [Related]
40. Oral manifestation of immunoproliferative small intestinal disease. A case report.
Bartold PM; Henning FR
J Periodontol; 1990 Nov; 61(11):710-3. PubMed ID: 2254838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
